Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.62 USD
Change Today +0.0399 / 6.88%
Volume 10.9K
CLTX On Other Exchanges
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Yuval Cohen Ph.D.

Former Senior Vice President and Director, Celsus Therapeutics Plc
AgeTotal Calculated CompensationThis person is connected to 7 board members in 2 different organizations across 3 different industries.

See Board Relationships


Dr. Yuval Cohen, Ph.D., has been the Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc. and Corbus Pharmaceuticals, Inc. Dr. Cohen served as Senior Vice President at Celsus Therapeutics Plc (formerly, Morria Biopharmaceuticals Plc) from February 2013 to December 10, 2013 and served as its President since January 12, 2005. Dr. Cohen served as the Managing Director of Celsus Therapeutics Plc. Dr. Cohen has been the driving force behind transforming MFAID ...

Read Full Background

Corporate Headquarters*

53 Davies street
London, Greater London W1K 5JH

United Kingdom

Phone: 44 20 3318 3004
Fax: 44 20 3322 1350

Board Members Memberships*

Chief Executive Officer and Director
Former Senior Vice President and Director
Chief Executive Officer and Director


University of Cape Town
Universite Rene Descartes Paris V

Other Affiliations*

Annual Compensation*

Total Annual Compensation$219,989

Stock Options*

Exercisable Options15,089
Unexercisable Options1,228,112
Total Number of Options1,593,201

Total Compensation*

Total Annual Cash Compensation$219,989
Total Short Term Compensation$219,989
Total Calculated Compensation$901,661
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLTX:US $0.62 USD +0.0399


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELSUS THERAPEUTICS-SPON ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at